London: The Oxford-AstraZeneca vaccine, whose Indian version is Covishield, is going through a rough phase. After 8 European nations temporarily suspended the vaccine due to possible blood clots, countries like Thailand are delaying its rollout.
The European Union’s drug regulator has now recommended adding severe allergy (anaphylaxis and hypersensitivity) as possible side effects.
This is based on 41 reports of possible anaphylaxis from around 5 million vaccinations in the UK.
It is important to note that the European Medicines Agency (EMA) is investigating the development of blood clots post vaccination, that prompted Italy, Norway and Denmark to suspend the jab. EMA, however, added that the vaccine is safe for use.
Anaphylaxis is known to be a common reaction to vaccines. The AstraZeneca shot carries a label that advises patients be kept under close observation for 15 minutes.
Also Read: Eight EU Nations Stop Using AstraZeneca Vaccine
Bhubaneswar: Hundreds of turtles being transported illegally were seized from a vehicle in Godipada area… Read More
Prayagrah/Bhubaneswar: Odisha Chief Minister Mohan Majhi along with his family took a holy dip in… Read More
Mumbai: At a time when the row over Ranveer Allahbadia’s crass comment on the ‘India’s… Read More
Dubai: The eyes of the cricketing world were focused on Dubai as India and Pakistan… Read More
Cuttack: Pankaj Lochan Mohanty on Sunday assumed charge as president of Odisha Cricket Association (OCA). Mohanty,… Read More
Kolkata: The Railway Protection Force (RPF) of Eastern Railway (ER) claimed to have seized foreign… Read More
This website uses cookies.
